thromboxane-a2 and Essential-Hypertension

thromboxane-a2 has been researched along with Essential-Hypertension* in 1 studies

Other Studies

1 other study(ies) available for thromboxane-a2 and Essential-Hypertension

Article	Year
Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A Pharmacological research, 2021, Volume: 170 Topics: Adult; Animals; Antifibrotic Agents; Antihypertensive Agents; Aspirin; Biomarkers; Blood Platelets; Blood Pressure; Cardiomyopathies; Case-Control Studies; Cells, Cultured; Disease Models, Animal; Essential Hypertension; Female; Fibrosis; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Myocytes, Cardiac; Myofibroblasts; Platelet Aggregation Inhibitors; Receptors, Epoprostenol; Receptors, Thromboxane; Thromboxane A2	2021

Article

Year

Low-dose Aspirin prevents hypertension and cardiac fibrosis when thromboxane A

Pharmacological research, 2021, Volume: 170

Topics: Adult; Animals; Antifibrotic Agents; Antihypertensive Agents; Aspirin; Biomarkers; Blood Platelets; Blood Pressure; Cardiomyopathies; Case-Control Studies; Cells, Cultured; Disease Models, Animal; Essential Hypertension; Female; Fibrosis; Humans; Male; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Myocytes, Cardiac; Myofibroblasts; Platelet Aggregation Inhibitors; Receptors, Epoprostenol; Receptors, Thromboxane; Thromboxane A2

2021